Compounds > celiprolol
Page last updated: 2024-10-24

celiprolol and Dyskinesia, Medication-Induced

celiprolol has been researched along with Dyskinesia, Medication-Induced in 3 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Sayeh, HG2
Rathbone, J2
Soares-Weiser, K2
Bergman, H1
Lyra da Silva, JP1
Hebenstreit, GF1
Hoffmann, H1
Hoffmann, W1
Pittner, H1

Reviews

2 reviews available for celiprolol and Dyskinesia, Medication-Induced

ArticleYear
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    The Cochrane database of systematic reviews, 2018, 01-18, Volume: 1

    Topics: Adrenergic Uptake Inhibitors; Anti-Dyskinesia Agents; Antipsychotic Agents; Celiprolol; Disease Prog

2018
Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Celiprolol; Dyskinesia, Drug-Induced; Humans; Randomiz

2006

Trials

1 trial available for celiprolol and Dyskinesia, Medication-Induced

ArticleYear
[Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Wiener klinische Wochenschrift, 1986, Jun-13, Volume: 98, Issue:12

    Topics: Adult; Aged; Antipsychotic Agents; Celiprolol; Clinical Trials as Topic; Double-Blind Method; Dyskin

1986